Financial Daily from THE HINDU group of publications
Tuesday, Jul 27, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals


Wockhardt Q2 net rises 43 pc

Our Bureau

Mumbai , July 26

WOCKHARDT has clocked a 43.1 per cent rise in its consolidated net profit at Rs 50.1 crore for the second quarter ended June 30, 2004.

Consolidated revenues from operations in the period under review rose 37 per cent to Rs 289.2 crore, a company communiqué issued here today said.

Meanwhile, for the first six months ended June 30 2004, the company's net profit and income from operations stood at Rs 94.6 crore and Rs 577.5 crore, respectively.

The second quarter also saw US regulatory approvals for Wockhardt's sterile bulk drug and formulation facilities.

Wockhardt is active in new drug discovery with three new molecules undergoing trials in India, the company said.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
India Cements posts Rs 18-cr loss


FCI OEN net down at Rs 1.97 crore
Nagarjuna Fert Q1 net down at Rs 5.75 cr
Sterling Biotech Q2 net up 62 pc
Zydus Cadila Q1 net rises 21 pc
Wockhardt Q2 net rises 43 pc
Tata Power net up by 2.2 pc in Q1
Raymond Q1 net dips to Rs 3.14 cr
Maruti first quarter net up 42 pc on higher sales
Blue Star Q1 net rises 36 pc at Rs 3.6 cr
Cognizant Q2 net rises to $23.8 m
Sonata Software Q1 net up 45 pc
Aptech Q1 net at Rs 5 cr as biz looks up
Hindware Q1 net up 60 pc
Titan reports 42 pc growth in sales
Dabur India posts higher Q1 net profit of Rs 20.5 cr; sales up 15.6 pc
Federal Bank Q1 net up 20 pc



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line